fective gut absorption by showing that oral ingestion of arginine in cystinurics was followed by minimal elevations of plasma arginine compared to results obtained with control subjects. We have previously reported a defect in the uptake of lysine and cystine by jejunal mucosa from cystinuric subjects (1) , an observation made simnultaneously by McCarthy and his associates (9) .
The present studies extend our previous observations and show that lysine and cystine are accumulated by saturable, energy-dependent processes in the human jejunum and that these two amino acids are mutually inhibitory in the gut. Furthermore, it is shown that some patients with cystinuria do not share the intestinal transport defect for cystine and lysine.
Methods
After an overnight fast, peroral biopsy of the intestinal mucosa was performed with a Rubin tube placed at the ligament of Treitz under fluoroscopic control. A total of 75 biopsies was performed on 18 normal volunteers and 12 patients with cystinuria. The 14 male and four female volunteers were between the ages of 18 and 36 years; the seven female and five male patients were between the ages of 19 and 48. All patients with cystinuria had elevated concentrations of cystine, lysine, arginine, and ornithine in the urine, and all had formed several urinary calculi composed of cystine.
The biopsy specimens weighing between 1 and 7 mg were placed in chilled, amino-acid free Krebs-Ringer bicarbonate buffer 5 to 10 minutes before incubation. The tissue was then transferred to 25-ml Erlenmeyer flasks containing 2.0 ml of Krebs-Ringer bicarbonate buffer (pH 7.4) and labeled amino acid. After aerobic (95%o 02-5% C02) or anaerobic (95%o N2-5% C02) incubation for 15 to 120 minutes at 370 C in a Dubnoff metabolic shaker, tissues were rinsed in saline, blotted, weighed, and placed in distilled water. The free amino acid content of the tissue was equilibrated with 1.0 ml of distilled water by boiling for 6 minutes. Two-tenthsml samples of aqueous tissue supernatant and remaining media were counted in a liquid scintillation spectrometer 442 with an efficiency of 57% for C". Samples of the aqueous tissue extracts were chromatographed with a one-dimensional paper system in butanol-acetic acidwater (4: 1: 2), and in all cases over 90% of the radioactivity was recovered at the appropriate Rf for the amino acid originally added to the medium. Total tissue water was determined to be the difference in weight before and after drying in a crucible for 24 hours at 1050 C in a vacuum oven. Extracellular fluid space (ECF) was defined as the space of distribution of C"-inulin. Distribution ratios defined as cpm/ml intracellular fluid (ICF)/ cpm/ml medium were calculated using the formula: cpm/ml ICF net tissue cpm-[(cpm/ml medium) X (inulin space)] ml tissue water-ml inulin space.
Distribution ratios were measured under steady-state conditions when feasible. A steady state exists when the rate of amino acid movement into the cell (influx) equals the rate of exit from the cell (efflux).
Analyses of the kinetics of the saturable component of biological transport (10) were carried out in the manner described by Akedo and Christensen (11 Figure  2 ), averaging data from four and three subjects respectively. The intestinal transport defect in cystinuria. Cystine, lysine, and arginine uptake by intestinal mucosa from patients with cystinuria was markedly impaired (Figure 3 ). (Table II and Figure 3) . These patients will be discussed in more detail subsequently.
To evaluate the possibility that patients with cystinuria can achieve normal intracellular concentrations of the involved amino acids, but at slower than normal rates, studies were carried out in which distribution ratios for lysine and cystine were measured after 15, 30, 45, and 90 minutes of incubation. The data presented in Figure 1A and 1 B indicate that tissue from patients with cystinuria did not concentrate cystine or lysine significantly at any of the time points studied. The inhibition of cystine by both concentrations of lysine was significant (p < 0.001 and <0.05, respectively). Glycine failed to inhibit transport of either amino acid.
Inhibition of cystine and lysine transport by unlabeled amino acids. Lysine accumulation in normal human intestinal mucosa was measured in the presence and absence of unlabeled arginine, cystine, and glycine, and cystine accumulation was measured in the presence and absence of unlabeled lysine and glycine. The data in Figure 4 indicate that lysine accumulation was inhibited by arginine and by both concentrations of cystine tested but not by glycine. Cystine accumulation was inhibited by both concentrations of lysine tested but not by glycine. It was not possible to obtain sufficient tissue from a single biopsy to determine whether the inhibition was competitive or noncompetitive, but the failure of glycine to inhibit the transport of either cystine or lysine suggests that the inhibition observed has some degree of specificity.
Discussion
In the present studies the findings of Spencer, Bow, Markulis, and Brody (14) demonstrating uptake of amino acids by intestinal mucosa in vitro have been confirmed and extended. It has been demonstrated that human intestinal mucosa is capable of accumulating amino acids by saturable transport mechanisms that are inhibited by anaerobiosis and uncoupling of oxidative phosphorylation. Since cystinuria was first viewed as a disease of altered sulfur metabolism (15) and later as a disease of renal tubular dysfunction (2), much of the work suggesting the presence of an intestinal transport defect was not fully appreciated. Thus the finding of putrescine and cadaverine in the urine and feces of a patient with cystinuria in 1890 (4) and the finding of impaired intestinal absorption of cystine in 1935 (5) and again in 1954 (6) were largely overlooked. The studies of Milne, Asatoor, and coworkers (7, 8) , indicating that an intestinal transport defect exists in cystinuria, have been confirmed by in vitro studies from this laboratory and by others (9) .
In the process of active transport by which a chemical concentration gradient is established between intracellular and extracellular fluid, both influx and efflux of amino acid are taking place. The failure to observe accumulation of cystine and the dibasic amino acids against a gradient in gut from cystinuric subjects may be due to a specific acceleration of efflux, but the time course of amino acid uptake (Figure 1 ) makes this possibility seem unlikely. These experiments demonstrate depressed intracellular concentrations of cystine and lysine in gut from cystinuric subjects at the earliest time point studied, suggesting that the rate of entry of these substances into the intracellular fluid has been markedly slowed. Such a slowing of influx would be expected if the specific carrier mechanism involved in the "uphill" transport of these amino acids were absent or defective.
The demonstration of an intestinal transport defect in cystinuria indicates that at least two tissues specifically modified for biological active transport are involved in this disease. Of potentially greater significance is the finding of a different defect in kidney and intestine in the same disorder. In human kidney cortex slices from cystinuric subjects, cystine accumulation was normal, but uptake of lysine and arginine was defective (2) . Furthermore, cystine did not share a transport mechanism with lysine, arginine, and ornithine. In the gut, cystine transport, as well as lysine and arginine transport, was defective in cystinuria, and cystine and lysine were mutually inhibitory. These differences in renal and intestinal transport were demonstrated by comparable experimental techniques, substrate concentrations, and inhibitor concentrations. Furthermore, the differences have been observed in three cystinuric patients (B.H., L.C., and P.C.) in whom both tissues were studied.
Animal studies have suggested that there is indeed a difference in the intestinal and renal handling of cystine and the dibasic amino acids. Although Hagihira, Lin, Samiy, and Wilson (16) showed that cystine could inhibit lysine transport in segments of hamster intestine, Rosenberg, Downing, and Segal (17) , using lower substrate concentrations, failed to demonstrate similar inhibition in kidney cortex slices from rat, dog, and monkey. The observed differences in renal and intestinal uptake may reflect in vitro artifacts rather than physiologically significant alterations, but Frimpter's recent observations suggest that this is unlikely (18) . He studied a single cystinuric subject and found a very high renal arteriovenous (a-v) difference for cysteine in the presence of an apparently normal a-v difference for cystine. He therefore suggested that plasma cysteine rather than cystine might be the source of urinary cystine in cystinuria. His results, coupled with the in vitro findings previously and presently reported from this laboratory, indicate that future investigations into the pathogenesis of this disorder must consider sulfhydryl-disulfide interaction between cysteine and cystine as well as transport mechanisms for cysteine in the gut and kidney.
Each of the thirteen cystinuric subjects had classical clinical cystinuria, characterized by cystine renal calculi and elevated urinary cystine, arginine, ornithine, and lysine. However, two of the 13 (V.H. and V.G.) were found to have intact intestinal transport mechanisms for cystine and only partially defective uptake of lysine and arginine. Although these results raise the possibility that cystinuria is more than one disease, they may equally well be explained on genetic grounds. The (Table II) .
His intestinal mucosa concentrated cystine and lysine as did that of V.H. and V.G., but he had had no cystine renal stones, nor was his urinary cystine elevated. Although there is adequate precedent for the "half-defect" phenomenon in other biochemical studies of human genetic disease (19, 20) , additional studies on families of patients with cystinuria are needed to determine whether uptake of amino acids by intestinal mucosa will provide a satisfactory genetic marker with which the mode of inheritance of cystinuria may be re-examined (21, 22 2. A defect in the transport of cystine and the dibasic amino acids is described in jejunal tissue from patients with cystinuria.
3. The intestinal transport defect in cystinuria appears to differ significantly from the previously reported renal defect. Cystine transport was defective in the intestine but not in the kidney, whereas dibasic amino acid transport was defective in both tissues. Furthermore, cystine and lysine were mutually inhibitory in the gut but not in the kidney.
4. Two patients with typical cystinuria had normal intestinal transport of cystine but reduced transport of arginine and lysine. A possible explanation of this phenomena on genetic grounds is presented.
